In addition, PTS was mainly performed in breast cancer with HR‐/HER2‐ subtype and advanced N classification, renal cancer patients with clear cell histology and advanced T classification, and colorectal cancer with advanced T and N classification. This evidence concerns the gene ERBB2 and breast carcinoma.